Over 30 million people in Europe live with a rare disease. Most of them still lack access to accurate diagnosis or treatment ...

Prof. Ganesan Karthikeyan, Executive Director of THSTI, opened the event by emphasizing the urgent need for multidisciplinary ...

A memo that purports to summarize a meeting held by members of a leading biotech trade group describes health secretary ...

The self-funded medical beauty market has gradually integrated into consumers' daily life, combining the pursuit of outer aesthetics with inner self-confidence, resulting in significant growth in the ...

Johannes Fruehauf left Germany for the United States more than 20 years ago to propel his scientific career. But amid ...

Dr. Annemarie Stroustrup has been tapped to head Northwell Health's pediatrics services at Cohen Children's Medical Center in ...

Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating ...

LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has received a letter from the Nasdaq Hearings Panel ...

Genomill Health’s Bridge Capture technology detects key mutations from blood samples in metastatic colorectal cancer patients: Turku, Finland Wednesday, July 16, 2025, 18:00 Hrs ...

Oscar-winning actress Lupita Nyong’o is sharing about her experience of being diagnosed with uterine fibroids, using the ...

Lumos Diagnostics signs exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of FebriDX in US.